Impact of an anti-inflammatory diet on patients with inflammatory bowel disease
Effects of Anti-inflammatory Diet on Inflammatory Markers, Anxiety, Depression and Quality of Life in Patients With Inflammatory Bowel Disease
This study is testing whether an anti-inflammatory diet can help people with inflammatory bowel disease feel better and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 88 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | The Fourth Affiliated Hospital of Zhejiang University School of Medicine Academic / other |
| Locations | 1 site (Yiwu, Zhejiang) |
| Trial ID | NCT06342011 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of an anti-inflammatory diet (AID) on patients diagnosed with inflammatory bowel disease (IBD). It involves a randomized controlled trial with 66 participants, who are divided into an experimental group receiving dietary intervention and a control group following standard care. The intervention lasts for 8 weeks, during which various inflammatory indicators and quality of life metrics are assessed before and after the dietary changes. The study aims to promote the use of AID in IBD management and explore new treatment strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older diagnosed with inflammatory bowel disease who can understand and comply with the dietary intervention.
Not a fit: Patients with cognitive impairments, mental illnesses, or those unable to participate due to deteriorating conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life and health outcomes for patients with inflammatory bowel disease through dietary management.
How similar studies have performed: While the specific approach of using an anti-inflammatory diet for IBD is novel, similar dietary interventions have shown promise in improving outcomes in other inflammatory conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Diagnosis of inflammatory bowel disease, the diagnostic criteria refer to the 2018 revised Consensus opinion on the diagnosis and treatment of inflammatory bowel disease; 2. The patient has clear consciousness and certain understanding, language expression and writing ability; 3. Patients participated in this study knowingly and voluntarily; 4. At least 18 years old. Exclusion Criteria: 1. cognitive impairment, mental illness, accompanied by mental disorders; 2. Alcohol and drug abusers. 3. The patient could not participate in the researcher due to the deterioration of the condition; 4. Patients who voluntarily quit due to other reasons; 5. Those who did not complete the assessment scale during the experiment.
Where this trial is running
Yiwu, Zhejiang
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine — Yiwu, Zhejiang, China (Recruiting)
Study contacts
- Principal investigator: Xia Qian, BA — The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Study coordinator: Xia Qian, BA
- Email: 1632936247@qq.com
- Phone: 15968110117
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.